AMAG PHARMACEUTICALS, INC.

MA

Pharmaceutical Company

Active 2020–2022.

Filings

13

Filed By

1

Reported In-House

—

Reported By Firms

$430,000

Filings

All 2022 2021 2020

Year	Firm	Period	Amount	Doc
2022	FARRAGUT PARTNERS LLP	4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination	$50,000
2022	FARRAGUT PARTNERS LLP	3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report	$50,000
2022	FARRAGUT PARTNERS LLP	2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report	$50,000
2022	FARRAGUT PARTNERS LLP	1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report	$50,000
2021	FARRAGUT PARTNERS LLP	4th Quarter (Oct 1 - Dec 31) AMENDED	$50,000
2021	FARRAGUT PARTNERS LLP	4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report	$50,000
2021	FARRAGUT PARTNERS LLP	3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report	$50,000
2021	FARRAGUT PARTNERS LLP	2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report	$50,000
2021	FARRAGUT PARTNERS LLP	1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report	$20,000
2020	FARRAGUT PARTNERS LLP	4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report	$20,000

Page 1 of 2 · 13 filings Next

Filed By

Firm	Filings	Amount
FARRAGUT PARTNERS LLP	13	$430,000

Issue Areas

Issue	Activities
Health Issues	13